文献速递血栓与止血

旋转血栓弹力法评估多种小鼠凝血障碍模型的止血特性及因子VIII治疗效果

Thromboelastometry assessment of hemostatic properties in various murine models with coagulopathy and the effect of factor VIII therapeutics.
PubMed 文献 · J Thromb Haemost · 2021-07-23

本研究用旋转血栓弹力法(ROTEM)评估多种遗传性出血或凝血障碍小鼠全血的止血特性,并观察因子VIII(FVIII)治疗在FVIIInull小鼠中的效果。结果显示,下腔静脉血可产生可靠结果,而尾静脉、眶后静脉丛或下颌静脉血则不能;FVIIInull与FIXnull小鼠的凝血时间(CT)和血凝块形成时间(CFT)显著延长,FVIII治疗呈剂量依赖性恢复止血。

要点

  • ROTEM仅下腔静脉血结果可靠,尾静脉等采血部位不适用。
  • FVIIInull与FIXnull小鼠CT、CFT显著延长,FV Leiden小鼠CT、CFT缩短。
  • 血小板或输注的FVIII呈剂量依赖性恢复FVIIInull小鼠止血。

核心结论

  • ROTEM是评估出血或凝血障碍小鼠模型止血特性及治疗效果的可靠且敏感的检测方法。

研究设计与样本

  • 研究使用遗传性凝血因子或血小板糖蛋白缺陷小鼠,采集枸橼酸化血并复钙后进行ROTEM分析。
  • 同时评估血小板源性或血浆源性FVIII的特性,以及FVIII治疗在FVIIInull小鼠中的效果。

主要发现

  • 下腔静脉血ROTEM结果可靠,尾静脉、眶后静脉丛或下颌静脉血则不可靠。
  • 年龄和性别对ROTEM测定的止血特性无显著影响。
  • 与野生型C57BL/6J小鼠相比,FVIIInull小鼠CT延长5倍、CFT延长9倍,FIXnull小鼠CT延长4倍、CFT延长5.7倍。
  • GPIIIanull小鼠CFT较野生型C57BL/6J小鼠显著延长8.4倍。
  • FV Leiden小鼠CT和CFT显著缩短、α角增大。

临床怎么用

  • 小鼠止血研究宜采用下腔静脉采血并以ROTEM评估凝血功能。
  • ROTEM可用于评价FVIII等止血治疗在小鼠模型中的剂量依赖性效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rotational thromboelastometry (ROTEM) has been commonly used to assess the viscoelastic properties of the blood clotting process in the clinic for patients with a hemostatic or prothrombotic disorder. OBJECTIVE: To evaluate the capability of ROTEM in assessing hemostatic properties in whole blood from various mouse models with genetic bleeding or clotting disease and the effect of factor VIII (FVIII) therapeutics in FVIIInull mice. METHODS: Mice with a genetic deficiency in either a coagulation factor or a platelet glycoprotein were used in this study. The properties of platelet- or plasma-FVIII were also assessed. Citrated blood from mice was recalcified and used for ROTEM analysis. RESULTS: We found that blood collected from the vena cava could generate reliable results from ROTEM analysis, but not blood collected from the tail vein, retro-orbital plexus, or submandibular vein. Age and sex did not significantly affect the hemostatic properties determined by ROTEM analysis. Clotting time (CT) and clot formation time (CFT) were significantly prolonged in FVIIInull (5- and 9-fold, respectively) and FIXnull (4- and 5.7-fold, respectively) mice compared to wild-type (WT)-C57BL/6J mice. Platelet glycoprotein (GP)IIIanull mice had significantly prolonged CFT (8.4-fold) compared to WT-C57BL/6J mice. CT and CFT in factor V (FV) Leiden mice were significantly shortened with an increased α-angle compared to WT-C57BL/6J mice. Using ROTEM analysis, we showed that FVIII expressed in platelets or infused into whole blood restored hemostasis of FVIIInull mice in a dose-dependent manner. CONCLUSION: ROTEM is a reliable and sensitive assay for assessing therapeutics on hemostatic properties in mouse models with a bleeding or clotting disorder.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Schroeder JA, Kuether EA, Fang J, et al. Thromboelastometry assessment of hemostatic properties in various murine models with coagulopathy and the effect of factor VIII therapeutics. J Thromb Haemost. 2021. PMID: 34245090. doi:10.1111/jth.15456

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。